MacroGenics Depreciation & Amortization 2011-2026 | MGNX

Annual Depreciation & Amortization MacroGenics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
7.17 M	7.54 M	9.64 M	11.9 M	11.3 M	12 M	12.3 M	9.16 M	7.23 M	7.61 M	2.86 M	1.82 M	1.2 M	1 M	1.1 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
12.3 M	1 M	6.91 M

Quarterly Depreciation & Amortization MacroGenics

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
1.69 M	-	-	1.77 M	-	-	-	1.84 M	-	-	-	2.98 M	-	8.63 M	5.79 M	2.91 M	-	8.31 M	5.51 M	2.73 M	-	9.07 M	6.1 M	3.08 M	-	9.24 M	6.18 M	2.9 M	-	5.27 M	2.54 M	1.34 M	-	5.89 M	3.98 M	1.98 M	-	5.63 M	3.56 M	1.77 M	-	1.67 M	1.18 M	546 K	-	1.32 M	835 K	398 K	-	317 K	518 K	252 K	-	236 K	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
9.24 M	236 K	3.37 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
Esperion Therapeutics ESPR	105 K	$ 3.13	-	$ 651 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 32.59	-6.89 %	$ 877 M	USA
Forte Biosciences FBRX	64 K	$ 21.59	-1.86 %	$ 280 M	USA
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Autolus Therapeutics plc AUTL	8.3 M	$ 1.7	3.03 %	$ 452 M	Britain
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Heron Therapeutics HRTX	2.31 M	$ 0.86	-1.42 %	$ 143 M	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Compugen Ltd. CGEN	475 K	$ 2.8	7.28 %	$ 262 M	Israel
Anika Therapeutics ANIK	5.37 M	$ 14.88	-0.93 %	$ 213 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Incyte Corporation INCY	93.3 M	$ 97.16	-0.26 %	$ 19 B	USA
Ionis Pharmaceuticals IONS	10 M	$ 75.56	-0.29 %	$ 12.1 B	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 3.4	-1.16 %	$ 5.6 M	Israel
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.61	2.55 %	$ 189 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA